Loading clinical trials...
Loading clinical trials...
This is an observational cohort study of clinical efficacy study.The purpose of this topic is to evaluate the efficacy and safety of Modified Liujunzi Decoction based on syndrome differentiation in pa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Peking University First Hospital
NCT03261934 · Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation
NCT05808010 · Chronic Atrophic Gastritis
NCT07152860 · Chronic Atrophic Gastritis
NCT06912178 · Chronic Atrophic Gastritis (CAG)
NCT05493124 · Chronic Atrophic Gastritis
Peking University First Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions